Table 3 Patients discharged with OAT or with any treatment (OAT/ASA), by the recommended treatment, before-and-after implementation.
2000 (N = 313) | 2004 (N = 388) | Absolute difference (2004–2000) in the prevalence of patients discharged with: | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Recommended treatment*: | Total | OAT | OAT or ASA | Total | OAT | OAT or ASA | OAT | OAT or ASA | ||||||
N | N | (%) | N | (%) | N | N | (%) | N | (%) | % | (95%CI) | % | (95%CI) | |
OAT strongly recommended | 106 | 60 | (56.6) | 91 | (84.8) | 105 | 86 | (81.9) | 101 | (96.2) | +25.3 | (14.9 34.9) | +10.3 | (3.9 17.2) |
OAT or ASA recommended | 101 | 41 | (40.6) | 67 | (66.3) | 124 | 68 | (54.8) | 103 | (83.1) | +14.2 | (3.2 24.8) | +16.7 | (7.2 26.2) |
Uncertain | 96 | 12 | (12.5) | 50 | (52.1) | 146 | 43 | (29.5) | 112 | (76.7) | +17.0 | (8.1 24.9) | +24.6 | (14.3 34.5) |
OAT not recommended | 10 | 2 | (20.0) | 5 | (50.0) | 13 | 1 | (7.7) | 8 | (61.5) | -12.3 | (-39.0 12.2) | +11.5 | (-20.6 41.1) |